source
- Sofinnova Partners raises €82 million to expand medtech creation strategy in Europe and U.S.Sofinnova Partners announced that it has secured €82 million ($93.3 million) in an oversubscribed financing round. The capital will be used to broaden the firm’s medtech creation strategy across Eu…
- Merck and Daiichi withdraw lung cancer ADC filing after FDA says data insufficientMerck and Daiichi Sankyo have pulled their application for accelerated approval of a B7-H3-directed antibody-drug conjugate aimed at extensive-stage small cell lung cancer. The FDA indicated that…